EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Synthesis and in vitro behavior of multivalent cationic lipopeptide



Synthesis and in vitro behavior of multivalent cationic lipopeptide








(PDF emailed within 1 workday: $29.90)

Accession: 021844396

Download citation: RISBibTeXText



Related references

Synthesis and in vitro behavior of multivalent cationic lipopeptide for DNA delivery and release in HeLa cells. Bioconjugate Chemistry 18(6): 1735-1738, 2007

Synthesis and characterization of a new multivalent cationic lipid for application in gene delivery. Biophysical Journal 82(1 Part 2): 524a, January, 2002

Preparation and in vitro release of melatonin-loaded multivalent cationic alginate beads. Archives of Pharmacal Research (Seoul) 19(4): 280-285, 1996

Synthesis and characterization of a new class of cationic protein polymers for multivalent display and biomaterial applications. Biomacromolecules 10(5): 1125-1134, 2009

Synthesis and characterization of degradable multivalent cationic lipids with disulfide-bond spacers for gene delivery. Biochimica et Biophysica Acta 1808(9): 2156-2166, 2011

Efficient synthesis and cell-transfection properties of a new multivalent cationic lipid for nonviral gene delivery. Journal of Medicinal Chemistry 45(23): 5023-5029, November 7, 2002

Structure-activity relationship of lipopeptide from outer membrane of Escherichia coli and synthesis of highly immunopotentiating lipopeptide derivatives with an achiral lipo-part. Chemical & Pharmaceutical Bulletin (Tokyo) 41(3): 627-629, 1993

Structure-activity relationship of lipopeptide from outer membrane of Escherichia coli and synthesis of highly immunopotenting lipopeptide derivatives with an achiral lipo-part. Chemical & Pharmaceutical Bulletin 41(3): 627-629, 1993

Modular synthesis of multivalent glycoarchitectures and their unique selectin binding behavior. Chemical Communications: 5851-5853, 2008

Synthetic multivalent glycopeptide-lipopeptide antitumor vaccines: impact of the cluster effect on the killing of tumor cells. Angewandte Chemie 53(6): 1699-1703, 2014

Synthetic approaches to multivalent lipopeptide dendrimers containing cyclic disulfide epitopes of foot-and-mouth disease virus. Bioconjugate Chemistry 14(1): 144-152, 2003

Carbohydrate-centered maleimide cluster as a new type of templates for multivalent peptide assembling. synthesis of multivalent HIV-1 gp41 peptides. Bioorganic & Medicinal Chemistry 11(1): 159-166, 2002

Carbohydrate-centered maleimide cluster as a new type of templates for multivalent peptide assembling: Synthesis of multivalent HIV-1 gp41 peptides. Bioorganic & Medicinal Chemistry 11(1): 159-166, 2 January, 2003

Cilofungin ly 121019 a new lipopeptide antibiotic inhibitor of cell wall synthesis in vitro activity on yeasts. Bulletin de la Societe Francaise de Mycologie Medicale 18(1): 31-46, 1989

Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers. Journal of the American Chemical Society 125(21): 6517-6531, 2003